drugset / Trial / NCT01957410

A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder

NCT01957410 ↗

Phase 2 Terminated 13 enrolled Janssen Research & Development, LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate if somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) obtained with electroencephalography (EEG) and electromyography (EMG) can be used to detect changes in cortical plasticity in responders to a single IV infusion of ketamine as compared to non-responders.

Timeline

Start
2014-02
Primary completion
2015-09
Completion
2015-09

Outcome

Outcome not reported

Stopped: “Clinical Team decision to terminate the study after the results from Cohort 1 did not support conducting Cohort 2.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous